Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT00368095 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Rajavithi Health Promotion Project (Population Base Cohort)

StatusActive, Not Recruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Re-verified, no change to tracked fieldsv7
  2. Trial status: Recruiting to Active, Not Recruiting
    • Primary completion date: Dec 2026
    • Study completion date: Aug 2016 to Dec 2026
    • Site details revised
    v6
  3. 2 versions Re-verified since Dec 26, 2007, no change to tracked fieldsv4-v5
  4. Eligibility criteria shortened, about 4 wordsv3
  5. Trial status: Not Yet Recruiting to Recruiting
    • Study sites: 0 to 1
    v2
  6. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Metabolic Syndrome (hypertension, diabetes mellitus, obesity, cerebrovascular-cardiovascular disease) In Community Survey was performed in central Bangkok. Prospective Cohort and intensive educated intervention (health promotion program in specific high risk groups) were performed. The aim of the study is to identify high risk patients who can develop serious complications from metabolic syndrome. An analysis of health outcomes in multiple dimensions will be performed.
Trial Details
NCT Number NCT00368095
Lead Sponsor Department of Medical Services Ministry of Public Health of Thailand
Collaborators: U.S. Department of Education
Conditions
(from sponsor)		 Diabetes Mellitus, Hypertension, Dyslipidemia, Obesity, Cardiovascular Disease, Coronary Artery Disease
Related terms Cardiovascular Diseases, Cerebrovascular Disorders, Coronary Artery Disease, Diabetes Mellitus, Dyslipidemias, Hypertension, Metabolic Syndrome, Myocardial Infarction, Obesity, Stroke
Enrollment 2,000 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov